SonoScape Medical Corp. (300633.SZ)
CNY 31.8
(-0.31%)
CNY 31.8
(-0.31%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 474.81 Million CNY | 24.16% |
| 2022 | 382.42 Million CNY | 77.33% |
| 2021 | 215.66 Million CNY | 588.23% |
| 2020 | -44.17 Million CNY | -141.43% |
| 2019 | 106.61 Million CNY | -60.76% |
| 2018 | 271.72 Million CNY | 30.84% |
| 2017 | 207.67 Million CNY | 162.2% |
| 2016 | 79.2 Million CNY | 4.32% |
| 2015 | 75.92 Million CNY | -36.73% |
| 2014 | 120 Million CNY | 107.93% |
| 2013 | 57.71 Million CNY | -54.68% |
| 2012 | 127.36 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 61.55 Million CNY | -50.79% |
| 2024 Q2 | 65.77 Million CNY | 6.85% |
| 2024 Q3 | -61.1 Million CNY | -192.9% |
| 2023 Q4 | 125.07 Million CNY | 113.38% |
| 2023 FY | 474.81 Million CNY | 24.16% |
| 2023 Q2 | 141.68 Million CNY | -5.18% |
| 2023 Q3 | 58.61 Million CNY | -58.63% |
| 2023 Q1 | 149.42 Million CNY | 28.12% |
| 2022 Q4 | 116.62 Million CNY | 43.8% |
| 2022 Q2 | 128.48 Million CNY | 128.56% |
| 2022 Q1 | 56.21 Million CNY | -23.79% |
| 2022 FY | 382.42 Million CNY | 77.33% |
| 2022 Q3 | 81.1 Million CNY | -36.87% |
| 2021 FY | 215.66 Million CNY | 588.23% |
| 2021 Q1 | 41.21 Million CNY | 153.32% |
| 2021 Q2 | 74.33 Million CNY | 80.36% |
| 2021 Q4 | 73.76 Million CNY | 180.03% |
| 2021 Q3 | 26.34 Million CNY | -64.57% |
| 2020 Q4 | -77.3 Million CNY | -3255.59% |
| 2020 Q3 | 2.44 Million CNY | -93.78% |
| 2020 Q2 | 39.39 Million CNY | 551.94% |
| 2020 Q1 | -8.71 Million CNY | -125.9% |
| 2020 FY | -44.17 Million CNY | -141.43% |
| 2019 FY | 106.61 Million CNY | -60.76% |
| 2019 Q4 | 33.65 Million CNY | 390.07% |
| 2019 Q2 | 68.69 Million CNY | 332.93% |
| 2019 Q1 | 15.86 Million CNY | -79.74% |
| 2019 Q3 | -11.6 Million CNY | -116.89% |
| 2018 Q3 | 60.19 Million CNY | -44.87% |
| 2018 Q4 | 78.32 Million CNY | 30.12% |
| 2018 FY | 271.72 Million CNY | 30.84% |
| 2018 Q1 | 24.02 Million CNY | -74.48% |
| 2018 Q2 | 109.18 Million CNY | 354.39% |
| 2017 Q3 | 35.04 Million CNY | -50.17% |
| 2017 Q1 | 8.15 Million CNY | -87.0% |
| 2017 FY | 207.67 Million CNY | 162.2% |
| 2017 Q2 | 70.31 Million CNY | 762.31% |
| 2017 Q4 | 94.16 Million CNY | 168.75% |
| 2016 Q2 | 20.63 Million CNY | 397.71% |
| 2016 FY | 79.2 Million CNY | 4.32% |
| 2016 Q4 | 62.73 Million CNY | 2167.38% |
| 2016 Q3 | 2.76 Million CNY | -86.59% |
| 2016 Q1 | -6.93 Million CNY | 0.0% |
| 2015 Q1 | 2.58 Million CNY | 0.0% |
| 2015 FY | 75.92 Million CNY | -36.73% |
| 2014 FY | 120 Million CNY | 107.93% |
| 2013 FY | 57.71 Million CNY | -54.68% |
| 2012 FY | 127.36 Million CNY | 0.0% |